These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3284095)

  • 21. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
    El Haggan W; Ficheux M; Debruyne D; Rognant N; Lobbedez T; Allard C; Coquerel A; Ryckelynck JP; Hurault de Ligny B
    Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
    Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C;
    Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
    Lück R; Böger J; Kuse E; Klempnauer J; Nashan B
    Liver Transpl; 2004 May; 10(5):686-91. PubMed ID: 15108262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2002.
    Gruessner AC; Sutherland DE
    Clin Transpl; 2002; ():41-77. PubMed ID: 12971436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic interactions between sirolimus and microemulsion cyclosporine when orally administered jointly and 4 hours apart in healthy volunteers.
    Zimmerman JJ; Harper D; Getsy J; Jusko WJ
    J Clin Pharmacol; 2003 Oct; 43(10):1168-76. PubMed ID: 14517200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals.
    Kahan BD; Dunn J; Fitts C; Van Buren D; Wombolt D; Pollak R; Carson R; Alexander JW; Choc M; Wong R
    Transplantation; 1995 Feb; 59(4):505-11. PubMed ID: 7878754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients.
    Akhlaghi F; Gonzalez L; Trull AK
    J Heart Lung Transplant; 2005 Dec; 24(12):2120-8. PubMed ID: 16364860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amlodipine, but not MDR1 polymorphisms, alters the pharmacokinetics of cyclosporine A in Japanese kidney transplant recipients.
    Kuzuya T; Kobayashi T; Moriyama N; Nagasaka T; Yokoyama I; Uchida K; Nakao A; Nabeshima T
    Transplantation; 2003 Sep; 76(5):865-8. PubMed ID: 14501869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation.
    Hangler HB; Ruttmann E; Geltner C; Bucher B; Nagiller J; Laufer G; Mueller LC
    Clin Transplant; 2008; 22(1):35-40. PubMed ID: 18217903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
    Midtvedt K; Fauchald P; Bergan S; Høieggen A; Hallan S; Svarstad E; Bergrem H; Eriksen BO; Pfeffer PF; Dalen I; Leivestad T
    Transplantation; 2003 Oct; 76(8):1236-8. PubMed ID: 14578761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The chronopharmacokinetics of cyclosporine and its metabolites in recipients of pancreas allografts.
    Canafax DM; Cipolle RJ; Hrushesky WJ; Rabatin JT; Min DI; Graves NM; Sutherland DE; Bowers LD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):471-7. PubMed ID: 3284092
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients.
    Yoshimura N; Nakai I; Ohmori Y; Aikawa I; Fukuda M; Yasumura T; Matsui S; Hamashima T; Oka T
    Am J Kidney Dis; 1988 Jul; 12(1):11-7. PubMed ID: 2455447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombosis in human pancreatic transplantation associated with elevated cyclosporine levels and possible protection by antihypertensive agents.
    Jennings WC; Smith J; Corry RJ
    J Okla State Med Assoc; 1990 Jun; 83(6):255-7. PubMed ID: 2374050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of cyclosporine on native renal function in non-uremic diabetic recipients of pancreas transplants.
    De Francisco AM; Mauer SM; Steffes MW; Goetz FC; Najarian JS; Sutherland DE
    J Diabet Complications; 1987; 1(4):128-31. PubMed ID: 2969385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: effects of binding and metabolism.
    Awni WM; Kasiske BL; Heim-Duthoy K; Rao KV
    Clin Pharmacol Ther; 1989 Jan; 45(1):41-8. PubMed ID: 2642778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of oral cyclosporin A in diabetic children and adolescents.
    Misteli C; Rey E; Pons G; Richard MO; d'Athis P; Legrand A; Bougneres P; Olive G
    Eur J Clin Pharmacol; 1990; 38(2):181-4. PubMed ID: 2338116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical variability of cyclosporine pharmacokinetics in adult and pediatric patients after renal, cardiac, hepatic, and bone-marrow transplants.
    Clardy CW; Schroeder TJ; Myre SA; Wadhwa NK; Pesce AJ; First MR; McEnery PT; Balistreri WF; Harris RE; Melvin DB
    Clin Chem; 1988 Oct; 34(10):2012-5. PubMed ID: 3048779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-dependent disposition of cyclosporine after pancreas transplantation, and application of chronopharmacokinetics to improve immunosuppression.
    Cipolle RJ; Canafax DM; Rabatin J; Bowers LD; Sutherland DE; Hrushesky WJ
    Pharmacotherapy; 1988; 8(1):47-51. PubMed ID: 3287355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of oral metoclopramide on the absorption of cyclosporine.
    Wadhwa NK; Schroeder TJ; O'Flaherty E; Pesce AJ; Myre SA; First MR
    Transplantation; 1987 Feb; 43(2):211-3. PubMed ID: 3544377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of food on cyclosporine absorption.
    Honcharik N
    Clin Biochem; 1991 Feb; 24(1):89-92. PubMed ID: 2060138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.